Helicobacter pylori and the risk of dementia: A population-based study

Alzheimer's and Dementia

Volumn 14, Issue 10, 2018, Pages 1377-1382

  Fani, Lana ^a   Wolters, Frank J ^a   Ikram, M Kamran ^a   Bruno, Marco J ^a   Hofman, Albert ^a,b   Koudstaal, Peter J ^a   Darwish Murad, Sarwa ^a   Ikram, M Arfan ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

Alzheimer's disease; Dementia; Helicobacter pylori; Infection; Longitudinal

Indexed keywords

1 ALKYL 2 ACETYLGLYCEROPHOSPHOCHOLINE ESTERASE; ALPHA 1 ANTITRYPSIN; APOLIPOPROTEIN E; C REACTIVE PROTEIN; CHOLESTEROL; FIBRINOGEN; HEMOGLOBIN; HIGH DENSITY LIPOPROTEIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HOMOCYSTEINE; IMMUNOGLOBULIN G; INTERLEUKIN 6; TRIACYLGLYCEROL; BACTERIUM ANTIBODY;

AGED; ALZHEIMER DISEASE; ANTIBODY TITER; ARTICLE; BLOOD; BODY MASS; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; COHORT ANALYSIS; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DEMENTIA; DIASTOLIC BLOOD PRESSURE; FEMALE; FIBRINOGEN BLOOD LEVEL; FOLLOW UP; HELICOBACTER PYLORI; HEMOGLOBIN BLOOD LEVEL; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; POPULATION BASED CASE CONTROL STUDY; PRIORITY JOURNAL; PROSPECTIVE STUDY; SEROPREVALENCE; SYSTOLIC BLOOD PRESSURE; TRIACYLGLYCEROL BLOOD LEVEL; HELICOBACTER INFECTION; IMMUNOLOGY; LONGITUDINAL STUDY; RISK FACTOR;

AGED; ANTIBODIES, BACTERIAL; DEMENTIA; FEMALE; FOLLOW-UP STUDIES; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; IMMUNOGLOBULIN G; INCIDENCE; LONGITUDINAL STUDIES; MALE; PROSPECTIVE STUDIES; RISK FACTORS;

EID: 85054153485     PISSN: 15525260     EISSN: 15525279     Source Type: Journal    
DOI: 10.1016/j.jalz.2018.05.005     Document Type: Article

References (32)

1. Brown, L.M., Helicobacter pylori: epidemiology and routes of transmission. Epidemiol Rev 22 (2000), 283–297.
2. Pellicano, R., Ribaldone, D.G., Fagoonee, S., Astegiano, M., Saracco, G.M., Megraud, F., A 2016 panorama of Helicobacter pylori infection: key messages for clinicians. Panminerva Med 58 (2016), 304–317.
3. Goodman, K.J., Joyce, S.L., Ismond, K.P., Extragastric diseases associated with Helicobacter pylori infection. Curr Gastroenterol Rep 8 (2006), 458–464.
4. Álvarez-Arellano, L., Maldonado-Bernal, C., Helicobacter pylori and neurological diseases: married by the laws of inflammation. World J Gastrointest Pathophysiol 5 (2014), 400–404.
5. Doulberis, M., Kotronis, G., Thomann, R., Polyzos, S.A., Boziki, M., Gialamprinou, D., et al. Impact of Helicobacter pylori on Alzheimer's disease: what do we know so far?. Helicobacter, 23, 2018.
6. Tchantchou, F., Shea, T.B., Folate deprivation, the methionine cycle, and Alzheimer's disease. Vitam Horm 79 (2008), 83–97.
7. Stettin, D., Waldmann, A., Strohle, A., Hahn, A., Association between Helicobacter pylori-infection, C-reactive protein and status of B vitamins. Adv Med Sci 53 (2008), 205–213.
8. Shindler-Itskovitch, T., Ravona-Springer, R., Leibovitz, A., Muhsen, K., A systematic review and meta-analysis of the association between helicobacterpylori infection and dementia. J Alzheimers Dis 52 (2016), 1431–1442.
9. Hofman, A., Brusselle, G.G., Darwish Murad, S., van Duijn, C.M., Franco, O.H., Goedegebure, A., et al. The Rotterdam Study: 2016 objectives and design update. Eur J Epidemiol 30 (2015), 661–708.
10. Mayerle, J., den Hoed, C.M., Schurmann, C., Stolk, L., Homuth, G., Peters, M.J., et al. Identification of genetic loci associated with Helicobacter pylori serologic status. JAMA 309 (2013), 1912–1920.
11. de Bruijn, R.F., Bos, M.J., Portegies, M.L., Hofman, A., Franco, O.H., Koudstaal, P.J., et al. The potential for prevention of dementia across two decades: the prospective, population-based Rotterdam Study. BMC Med, 13, 2015, 132.
12. Kountouras, J., Tsolaki, F., Tsolaki, M., Gavalas, E., Zavos, C., Polyzos, S.A., et al. Helicobacter pylori-related ApoE 4 polymorphism may be associated with dysphagic symptoms in older adults. Dis Esophagus, 29, 2016, 842.
13. Darweesh, S.K.L., Wolters, F.J., Ikram, M.A., de Wolf, F., Bos, D., Hofman, A., Inflammatory markers and the risk of dementia and Alzheimer's disease: a meta-analysis. [Epub ahead of print]. Alzheimers Dement, 2018 Mar 29 https://doi.org/10.1016/j.jalz.2018.02.014.
14. Roubaud Baudron, C., Letenneur, L., Langlais, A., Buissonniere, A., Megraud, F., Dartigues, J.F., et al. Does Helicobacter pylori infection increase incidence of dementia? The Personnes Agees QUID Study. J Am Geriatr Soc 61 (2013), 74–78.
15. Huang, W.S., Yang, T.Y., Shen, W.C., Lin, C.L., Lin, M.C., Kao, C.H., Association between Helicobacter pylori infection and dementia. J Clin Neurosci 21 (2014), 1355–1358.
16. den Hoed, C.M., Vila, A.J., Holster, I.L., Perez-Perez, G.I., Blaser, M.J., de Jongste, J.C., et al. Helicobacter pylori and the birth cohort effect: evidence for stabilized colonization rates in childhood. Helicobacter 16 (2011), 405–409.
17. van Blankenstein, M., van Vuuren, A.J., Looman, C.W., Ouwendijk, M., Kuipers, E.J., The prevalence of Helicobacter pylori infection in the Netherlands. Scand J Gastroenterol 48 (2013), 794–800.
18. Yamaoka, Y., Mechanisms of disease: helicobacter pylori virulence factors. Nat Rev Gastroenterol Hepatol 7 (2010), 629–641.
19. Jenks, P.J., Megraud, F., Labigne, A., Clinical outcome after infection with Helicobacter pylori does not appear to be reliably predicted by the presence of any of the genes of the cag pathogenicity island. Gut 43 (1998), 752–758.
20. Lai, C.H., Kuo, C.H., Chen, Y.C., Chao, F.Y., Poon, S.K., Chang, C.S., et al. High prevalence of cagA- and babA2-positive Helicobacter pylori clinical isolates in Taiwan. J Clin Microbiol 40 (2002), 3860–3862.
21. Weel, J.F., van der Hulst, R.W., Gerrits, Y., Roorda, P., Feller, M., Dankert, J., et al. The interrelationship between cytotoxin-associated gene A, vacuolating cytotoxin, and Helicobacter pylori-related diseases. J Infect Dis 173 (1996), 1171–1175.
22. Tchantchou, F., Homocysteine metabolism and various consequences of folate deficiency. J Alzheimers Dis 9 (2006), 421–427.
23. Shadfar, S., Hwang, C.J., Lim, M.S., Choi, D.Y., Hong, J.T., Involvement of inflammation in Alzheimer's disease pathogenesis and therapeutic potential of anti-inflammatory agents. Arch Pharm Res 38 (2015), 2106–2119.
24. Heppner, F.L., Ransohoff, R.M., Becher, B., Immune attack: the role of inflammation in Alzheimer disease. Nat Rev Neurosci 16 (2015), 358–372.
25. Min, J.Y., Min, K.B., The Folate-Vitamin B12 Interaction, Low Hemoglobin, and the Mortality Risk from Alzheimer's Disease. J Alzheimers Dis 52 (2016), 705–712.
26. Hoepelman, A.I., Test for HIV and syphilis too in suspected early dementia. BMJ, 344, 2011, d8213.
27. Almeida, O.P., Lautenschlager, N.T., Dementia associated with infectious diseases. Int Psychogeriatr 17 Suppl 1 (2005), S65–S77.
28. Dunn, N., Mullee, M., Perry, V.H., Holmes, C., Association between dementia and infectious disease: evidence from a case-control study. Alzheimer Dis Assoc Disord 19 (2005), 91–94.
29. Sochocka, M., Zwolinska, K., Leszek, J., The infectious etiology of Alzheimer's disease. Curr Neuropharmacol 15 (2017), 996–1009.
30. Khalifehgholi, M., Shamsipour, F., Ajhdarkosh, H., Ebrahimi Daryani, N., Pourmand, M.R., Hosseini, M., et al. Comparison of five diagnostic methods for Helicobacter pylori. Iran J Microbiol 5 (2013), 396–401.
31. Kountouras, J., Boziki, M., Gavalas, E., Zavos, C., Deretzi, G., Grigoriadis, N., et al. Increased cerebrospinal fluid Helicobacter pylori antibody in Alzheimer's disease. Int J Neurosci 119 (2009), 765–777.
32. Attallah, A.M., Toson, E.A., Ibrahim, G.G., Bakr, N.E., Detection of a Helicobacter pylori antigen in cerebrospinal fluid of patients with meningitis. J Immunoassay Immunochem 28 (2007), 25–33.